Hierarchical Linear Models for Multiregional Clinical Trials

被引:6
|
作者
Kim, Saemina [1 ]
Kang, Seung-Ho [1 ]
机构
[1] Yonsei Univ, Dept Appl Stat, 262 Seongsanno, Seoul 120749, South Korea
来源
基金
新加坡国家研究基金会;
关键词
Between-cluster variability; Mixed effect model; Permutation test; Random coefficient model; SAMPLE-SIZE; CONSISTENCY ASSESSMENT; JAPANESE PATIENTS; DESIGN; REGIONS;
D O I
10.1080/19466315.2019.1654914
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Data observed in multiregional clinical trials are structurally hierarchical in the sense that the patient population consists of several regions and patients are nested within their own regions. To reflect such hierarchical structure, in this article, we propose two-level hierarchical linear models in which the level-1 model is based on patient-level data such as treatment indicator and age, and the level-2 model is based on region-level data such as medical practices. The fixed effect model and the continuous random effect model are shown to be special cases of hierarchical linear models. We conducted simulation studies to investigate the empirical Type I error rates of three methods for testing the overall treatment effect. The performance of the testing method with sample ratios as weights and the empirical Bayes estimator for between-region variability is better than that of the other two testing methods.
引用
收藏
页码:334 / 343
页数:10
相关论文
共 50 条
  • [21] Integration of patient-reported outcomes in multiregional confirmatory clinical trials
    Gnanasakthy, Ari
    DeMuro, Carla
    Boulton, Caroline
    [J]. CONTEMPORARY CLINICAL TRIALS, 2013, 35 (01) : 62 - 69
  • [22] Potential Factors Influencing Regional Differences and Similarities in Multiregional Clinical Trials
    Ohishi, Masahiko
    [J]. DRUG INFORMATION JOURNAL, 2012, 46 (05): : 565 - 572
  • [23] Impact of Different Regulatory Requirements for Trial Endpoints in Multiregional Clinical Trials
    Girman, Cynthia J.
    Ibia, Ekopimo
    Menjoge, Shailendra
    Mak, Carmen
    Chen, Joshua
    Agarwal, Anupum
    Binkowitz, Bruce
    [J]. DRUG INFORMATION JOURNAL, 2011, 45 (05): : 587 - 594
  • [24] Potential Factors Influencing Regional Differences and Similarities in Multiregional Clinical Trials
    Masahiko Ohishi
    [J]. Drug information journal : DIJ / Drug Information Association, 2012, 46 : 565 - 572
  • [25] Multicollinearity in hierarchical linear models
    Yu, Han
    Jiang, Shanhe
    Land, Kenneth C.
    [J]. SOCIAL SCIENCE RESEARCH, 2015, 53 : 118 - 136
  • [26] Unified additional requirement in consideration of regional approval for multiregional clinical trials
    Teng, Zhaoyang
    Chen, Yeh-Fong
    Chang, Mark
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2017, 27 (06) : 903 - 917
  • [27] HLM: Hierarchical Linear Models
    Iacobucci, Dawn
    [J]. ADVANCES IN CONSUMER RESEARCH, VOL XXXVI, 2009, 36 : 813 - 813
  • [28] Impact of Different Regulatory Requirements for Trial Endpoints in Multiregional Clinical Trials
    Cynthia J. Girman
    Ekopimo Ibia
    Shailendra Menjoge
    Carmen Mak
    Joshua Chen
    Anupam Agarwal
    Bruce Binkowitz
    [J]. Drug information journal : DIJ / Drug Information Association, 2011, 45 : 587 - 594
  • [29] Hierarchical generalized linear models
    Lee, Y
    Nelder, JA
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-METHODOLOGICAL, 1996, 58 (04): : 619 - 656
  • [30] Application of Bayesian hierarchical models for phase I/II clinical trials in oncology
    Yada, Shinjo
    Hamada, Chikuma
    [J]. PHARMACEUTICAL STATISTICS, 2017, 16 (02) : 114 - 121